TScan Therapeutics Asset Turnover Growth & History (TCRX)

TScan Therapeutics's asset turnover was 0.03 for fiscal 2025.

View full TScan Therapeutics company overview

TScan Therapeutics annual asset turnover history

TScan Therapeutics annual asset turnover

Fiscal yearPeriod endedAsset turnoverChangeGrowth
20252025-12-310.030.03+293.16%
20242024-12-310.01−0.08−90.20%
20232023-12-310.090.02+27.78%
20222022-12-310.07−0.02−18.01%
20212021-12-310.09

TScan Therapeutics asset turnover trends

Between the periods ended 2021-12-31 and 2025-12-31, TScan Therapeutics's asset turnover decreased from 0.09 to 0.03, a change of −0.05. The latest reported quarter, Q2 2026, shows 0.03.

About the metric

What asset turnover means

Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.

Calculation and source

How asset turnover is calculated

TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review TScan Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about TCRX yet. Start the conversation.

Write the first post